StageAcquired | Acquired
About CymoGen Dx
CymoGen Dx operates as a genomic diagnostic technology company. It provides genomic-based reagents and fluorescent in-situ hybridization probes research products and solutions for the diagnosis and monitoring of cancers and human genetic disorders for clinical, biopharmaceutical, and research customers. The company was founded in 2010 and is based in New Winsdor, New York. In October 2014, CymoGen Dx was acquired by Biocare Medical. The terms of the transaction were not disclosed.
Missing: CymoGen Dx's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: CymoGen Dx's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing CymoGen Dx
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CymoGen Dx is included in 1 Expert Collection, including Cancer.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Latest CymoGen Dx News
Nov 23, 2022
Biocare Medical announces agreement to acquire Cymogen DX Concord, California, October 3, 2014 – Biocare Medical, LLC is proud to announce that they have entered into an agreement to acquire New Windsor, NY based CymoGen Dx, LLC. “CymoGen’s broad product line of Next-Gen™ FISH [Fluorescent in situ Hybridization] probes for detection of genetic anomalies in tissue samples adds to Biocare’s growing presence in the Molecular Diagnostics Market,” said Roy Yih, CEO of Biocare. “Of particular importan
CymoGen Dx Frequently Asked Questions (FAQ)
When was CymoGen Dx founded?
CymoGen Dx was founded in 2010.
Where is CymoGen Dx's headquarters?
CymoGen Dx's headquarters is located at 4 London Avenue, New Windsor.
What is CymoGen Dx's latest funding round?
CymoGen Dx's latest funding round is Acquired.
How much did CymoGen Dx raise?
CymoGen Dx raised a total of $350K.
Who are the investors of CymoGen Dx?
Investors of CymoGen Dx include Biocare Medical.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.